Literature DB >> 3088384

Purification of rat monoclonal antibodies.

H Bazin, F Cormont, L De Clercq.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3088384     DOI: 10.1016/0076-6879(86)21063-0

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  6 in total

1.  Cryoglobulinemia induced by a murine IgG3 rheumatoid factor: skin vasculitis and glomerulonephritis arise from distinct pathogenic mechanisms.

Authors:  L Reininger; T Berney; T Shibata; F Spertini; R Merino; S Izui
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

2.  Rheumatoid factors in mice bearing the lpr or gld mutation. Selective production of rheumatoid factor cryoglobulins in MRL/MPJ-lpr/lpr mice.

Authors:  T Shibata; T Berney; F Spertini; S Izui
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

3.  Role of the major histocompatibility complex class II Ea gene in lupus susceptibility in mice.

Authors:  N Ibnou-Zekri; M Iwamoto; L Fossati; P J McConahey; S Izui
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

4.  Immunoglobulin heavy chain constant region determines the pathogenicity and the antigen-binding activity of rheumatoid factor.

Authors:  T Fulpius; F Spertini; L Reininger; S Izui
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

5.  Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice.

Authors:  S Takahashi; L Fossati; M Iwamoto; R Merino; R Motta; T Kobayakawa; S Izui
Journal:  J Clin Invest       Date:  1996-04-01       Impact factor: 14.808

6.  Prevention of systemic lupus erythematosus in autoimmune BXSB mice by a transgene encoding I-E alpha chain.

Authors:  R Merino; M Iwamoto; L Fossati; P Muniesa; K Araki; S Takahashi; J Huarte; K Yamamura; J D Vassalli; S Izui
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.